BigHat Biosciences

Develops antibody therapies using artificial intelligence and synthetic biology.

BiotechnologyPharmaceuticals

Company facts

Founded
2019
Employees
98
Headquarters
United States
Type
Private
Funding
Series B · $124M · 2025
Subsidiaries
Frugi Biotechnology